Pricing

Attralus Therapeutics

0 followers

‌

Attralus is a clinical stage biopharmaceutical company focused on creating transformative medicines to improve the lives of patients with systemic amyloidosis.

Industries

Biotechnology

Headquarters

South San Francisco, United States

Employees

11-50

Links

Org chart

Mark Timney

CEO

Mark Timney

Collapse

Spencer Guthrie

Co-Founder & COO

Glen Firestone

Chief Business Officer

Gregory Bell

Chief Medical Officer

Jonathan Wall

Co-Founder & Interim Chief Scientific Officer

James Testa

VP, Finance

Michael L. Klein

Head, CMC

Christine Huh

Head, Human Resources

Andy Vick

Vice President, Head Of Toxicology, Drug Disposition, And Pk/pd

Daniel Kim

Associate Director, Translational Medicine Operations

Lesley Davis

Director Of Quality

Mike Klein

Senior Vice President, Head of CMC

Nicolas Angell

Executive Director, Analytical and Formulation Development

Dave Conroy

Head of Program Management

Matthew Meldorf

Senior Vice President Clinical Development

Teams

+10

Regulatory and Scientific Development

13 members

Clinical Operations and Development

7 members

Leadership Team

6 members

Similar companies

Entos

1 follower

Vertex Pharmaceuticals

55 followers

AbbVie

166 followers

Tessera Therapeutics

2 followers

Vaxcyte

2 followers

Immunome

2 followers

Apogee Therapeutics

1 follower

Artiva Biotherapeutics

1 follower

Thermo Fisher Scientific

158 followers

Genentech

150 followers

AICPA

2 followers

Explore companies